🏅 Wednesday Win 🏆 Becker's Healthcare declared that Realyze Intelligence "HIT BIG 💥 in the last two months" sharing that our back-to-back publications in Journal of Clinical Oncology CCI and JAMA Surgery "further validate the company's AI platform as a tool to match cancer patients with clinical trials" ✅ The declaration was part of a celebration of thriving UPMC Enterprises companies -- including our friends at eVisit, Pip Care & BlueSphere Bio. We agree. We've had a BIG year so far... but we're only getting started 🚀 #ClinicalTrialsForAll #NoMoreZombieTrials #ClinicalTrialInnovation #AIinPrecisionOncology #AIOncology #CloseTheCareGap #CancerX #CancerXAccelerator #BeckersMention #RealyzeIntelligence
Realyze Intelligence
Information Technology & Services
Pittsburgh, PA 744 followers
We combine AI & clinical expertise to accelerate clinical trials, harmonize RWD & drive patient outcomes.
About us
Realyze Intelligence has developed a suite of tools to facilitate clinical trial matching & data abstraction – together these tools can: - Accelerate screening & matching of patients to oncology clinical trials - Provide auto-abstraction for Real World Data needs (registry, research, etc) - Identify care pathways and pathway adherence The Realyze solution enables clinical oncology research sites to increase enrollment, target more diverse populations and turbocharge clinical research capabilities using existing resources. Our goal is to be a force-multiplier for existing oncology clinical trial & research teams. The Realyze platform leverages a combination of AI, LLMs and clinically guided expert models to analyze EHR data in real time, instantly matching patients to clinical trials. Additionally, the solution captures and makes available all the key clinical data from the unstructured notes to allow it to be imported back into the EMR, improving research and other clinical uses. -- Realyze has provided a 5x increase in patient matching for oncology clinical trials, including expanding the target locations and demographics for the identified populations. -- Realyze has processed and analyzed over 3 million patient records and well over 10 million individual medical documents across 36 different source systems/EMRs. -- Clinical teams using the Realyze intelligence solution have seen a reduction in trial screening time from 1-2 hours to under a minute per patient. -- The Realyze solution augments existing workflows and integrates the data back into EMRs & CTMSs. -- The Realyze solution acts as a force-multiplier for your existing team – freeing them from the drudgery of screening & abstraction. -- The Realyze platform has been used to identify patients to optimize value-based care programs, registry entry, care coordination, & research. -- Realyze collaborates w. leading health systems such as Memorial Sloan Kettering Cancer Center, OneOncology & UPMC.
- Website
-
http://realyzeintelligence.com
External link for Realyze Intelligence
- Industry
- Information Technology & Services
- Company size
- 11-50 employees
- Headquarters
- Pittsburgh, PA
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Healthcare, Technology, Healthcare Data, Natural Language Processing, Artificial Intelligence, Clinical Natural Language Processing, Electronic Medical Records, Oncology, Clinical Trials , Precision Oncology, Data Abstraction, Real-World Data , Natural Language Understanding , Oncology Research, Oncology Clinical Trials , Healthcare Disparity, Oncology Disparity , RWD Harmonization, Clinical Pathways, and Consulting
Locations
-
Primary
6245 Penn Ave
#200
Pittsburgh, PA 15206, US
Employees at Realyze Intelligence
-
Aaron Brauser
Co-founder and Chief Executive Officer at Realyze Intelligence
-
Craig B.
Healthcare Investor | UPMC Enterprises
-
Samantha Lavrinc
NLP Software Engineer at Realyze Intelligence | Medical Research and Development
-
Nathaniel Brauser
Student at University of Pittsburgh studying computer science and data science.
Updates
-
🔜 🗓 ✔ ONE MONTH FROM TODAY : October 3, 2024, at 3:00pm ET The Center for Connected Medicine at UPMC is hosting a webinar entitled : "Optimizing Clinical Trials at Health Systems: The Opportunity for AI" This insightful discussion will be moderated by Nicole Ansani, Senior Vice President of New Development Initiatives at UPMC Enterprises The expert panel will include Realyze Intelligence's very own CEO Aaron Brauser along with Matthew Lunning from the University of Nebraska Medical Center and Stefan Harrer, PhD, from CSIRO's Data61. The panelists will explore the transformative potential of hashtag #AI #clinicaltrials - no surprise, we're pretty pumped to share our perspective! 🔗 Register HERE : https://lnkd.in/eRscpqUP #ClinicalTrialsForAll #CancerX #CancerXAccelerator #NoMoreZombieTrials #AIOncology #AIinPrecisionOncology #ClinicalTrialInnovation
-
-
Such a honor to be recognized by Becker's Healthcare and part of the UPMC Enterprises portfolio !
Becker's Healthcare recognizes the power of our portfolio 👏 In 2024, the UPMC Enterprises portfolio companies continue to achieve national recognition for their innovation in #digitalhealth and #lifesciences. 💻 eVisit joined the UPMC Enterprises portfolio as they acquired our inpatient teleconsult technology. 🧬 Realyze Intelligence supported two UPMC studies published in the Journal of Clinical Oncology and JAMA Surgery. 🩺 Pip Care published findings supporting the effectiveness of their #surgicaloptimization platform. 💊BlueSphere Bio earned its first IND clearance from the FDA and announced several new collaborations. Read the full article here: https://lnkd.in/eMJkJYrN
-
Realyze Intelligence reposted this
Becker's Healthcare recognizes the power of our portfolio 👏 In 2024, the UPMC Enterprises portfolio companies continue to achieve national recognition for their innovation in #digitalhealth and #lifesciences. 💻 eVisit joined the UPMC Enterprises portfolio as they acquired our inpatient teleconsult technology. 🧬 Realyze Intelligence supported two UPMC studies published in the Journal of Clinical Oncology and JAMA Surgery. 🩺 Pip Care published findings supporting the effectiveness of their #surgicaloptimization platform. 💊BlueSphere Bio earned its first IND clearance from the FDA and announced several new collaborations. Read the full article here: https://lnkd.in/eMJkJYrN
UPMC Enterprises portfolio companies thrive
beckershospitalreview.com
-
✨ Kickstart your long weekend with this inspiring conversation! Dr. Ruben Mesa, MD & Dr. Naveen Pemmaraju, MD had a powerful & must-listen conversation about clinical trials at an MPN Advocacy & Education International event earlier this month. Whether you are a clinician, patient, researcher, industry-partner or advocate - you'll be inspired AND learn something during this discussion. Every new cancer clinical trial brings us closer to breakthroughs that can transform the way cancer is treated, offering hope and improved quality of life to patients today & tomorrow. At Realyze Intelligence - we're firm believers in the power of research as care. Our platform enables more cancer patients to participate in clinical trials and empowers clinicians with data insights at their fingertips. Win-Win. #ClinicalTrialsForAll #NoMoreZombieTrials #AIOncology #AIinPrecisionOncology #ClinicalTrialInnovation #CloseTheCareGap https://lnkd.in/gQk9CDZ2
A Conversation about Clinical Trials
https://www.youtube.com/
-
📰 Did you catch it? Realyze Intelligence was featured by the Pittsburgh Business Times! Our CEO Aaron Brauser highlighted the transformative power of our platform: 🔬 💡 "We kind of look at it as like a microscope... until someone invented the microscope, there weren't a lot of cell level discoveries that happened. Once we get this data and the technology there, we're going to be able to find new ways to use the data and have abilities to solve problems we couldn't have even imagined." Our partners are already using Realyze to : ✅ Accelerate precise patient matching to clinical trials ✅ Slay zombie trials & inform clinical trial feasibility queries ✅ Turbocharge Real World Data driven research questions ✅ Implement right sized care to improve patient outcomes ✅ Simplify & expedite data registry abstraction What will YOU do with the Realyze platform? #ClinicalTrialInnovation #RealyzeIntelligence #AIinPrecisionOncology #CancerResearch #CancerInnovation #NoMoreZombieTrials Find the link to the article in the comments
-
The Center for Connected Medicine at UPMC recently released their annual “Top of Mind for Top Health Systems” survey. ▶ For the second year in a row, #AI has been highlighted as the most exciting and improved technology by surveyed health care leaders. Realyze Intelligence is already helping multiple health systems accelerate clinical trials & unlock RWD at the patient level using our human-in-the-loop AI Further key insights from respondent health care leaders : - 85% identified AI as the most exciting technology in health care right now - Approximately one third saw AI's potential in clinical care & decision support - Health care organizations continue to prioritize leveraging technology to solve challenges with patient care, patient access, and provider burnout 📥 Download the survey for more detailed insights from leadership. https://lnkd.in/g-atTS84
Excitement for AI’s Potential in Health Care Grows as Progress is Observed
https://connectedmed.com
-
✨ The Future of Oncology Is Here. Are You Ready? ✨ In a new editorial for American Society of Clinical Oncology (ASCO) Daily News, Dr. Matthew Kurian, MD and Dr. Douglas Flora, MD, LSSBB, FACCC discuss how AI is already used in many diagnostic tools and stress the need to better understand these technologies in order to bring AI into everyday practice "AI-based technology is slowly becoming interwoven within the everyday life and workflow of oncologists today." Read more : https://lnkd.in/evhz4dvW #AIOncology #AIinPrecisionOncology #ASCO24 #FutureofOncology #ClinicalTrialsForAll #NoMoreZombieTrials #RealyzeIntelligence
-
-
⁉ Is AI a Game Changer for Clinical Trials ⁉ At Realyze Intelligence we've built human-in-the-loop & clinical-trained AI solutions that deliver ease & value for our partners. Imagine screening patients in minutes instead of hours, unlocking deep insights from real-world data (RWD), and earning a stellar reputation with trial sponsors— all while accelerating patient accruals. Here’s how the Realyze platform is meeting the AI hype: ⏰ Speed Up Patient Screening: Transform hours of work into minutes, allowing your team to screen more patients with the same resources. 🔑 Unlock Patient-Level RWD Insights: Gain access to over 180+ standardized data elements per patient, helping you find the right candidates faster. *bonus* having all that data at your fingertips makes feasibility queries a breeze 📈 Boost Accrual Rates & Patient Diversity: Users have seen accrual rates triple, naturally attracting more diverse patient cohorts. Ready to supercharge your trials? Let’s discuss your goals, explore a live demo, and answer your questions. Schedule a session today! 💪 #AI #ClinicalTrials #Oncology #PatientAccruals #HealthcareInnovation #RealWorldData #AIinPrecisionOncology #AIOncology #NoMoreZombieTrials #RealyzeIntelligence
-
🔜 🗓 ✔ Mark Your Calendar : October 3, 2024, at 3:00pm ET The Center for Connected Medicine at UPMC is hosting a webinar entitled : "Optimizing Clinical Trials at Health Systems: The Opportunity for AI" This insightful discussion will be moderated by Nicole Ansani, Senior Vice President of New Development Initiatives at UPMC Enterprises The expert panel will include Realyze Intelligence's very own CEO Aaron Brauser along with Matthew Lunning from the University of Nebraska Medical Center and Stefan Harrer, PhD, from CSIRO's Data61. The panelists will explore the transformative potential of #AI in #clinicaltrials - no surprise, we're pretty pumped to share our perspective! 🔗 ⬇ Find the link to register in the comments #ClinicalTrialsForAll #CancerX #CancerXAccelerator #NoMoreZombieTrials #AIOncology #AIinPrecisionOncology #ClinicalTrialInnovation
-